Integrated Molecular Analysis of Tamoxifen-Resistant Invasive Lobular Breast Cancer Cells Identifies MAPK and GRM/mGluR Signaling as Therapeutic Vulnerabilities

Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathological, and molecular features that distinguish it from the more common invasive ductal carcinoma (IDC). Mounting evidence suggests that estrogen receptor-alpha positive (ER+) ILC has a poor response to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cell Endocrinol
Main Authors: Stires, Hillary, Heckler, Mary M., Fu, Xiaoyong, Zhao, Li, Grasso, Catherine S., Quist, Michael J., Lewis, Joseph A., Klimach, Uwe, Zwart, Alan, Mahajan, Akanksha, Győrffy, Balázs, Cavalli, Luciane R., Riggins, Rebecca B.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5858970/
https://ncbi.nlm.nih.gov/pubmed/28935545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2017.09.024
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares